Clin2
NCT06641466Likely a fitRecruiting

Study of Rimegepant for preventing menstrual migraine in women

Menstrual Migraine

Treatments studied

Part of Brain & nervous system, Women’s health & pregnancy clinical trials.

This study tests whether the medicine rimegepant can help prevent migraines that happen around your period. It is for women with regular menstrual cycles who have a history of menstrual migraines.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
723 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You have regular periods, coming every 24 to 34 days
  • You have had migraines (with or without aura) for at least 1 year
  • You have had migraines linked to your period for at least 3 months
  • You had at least 1 migraine during or right before your period in 2 of the last 3 cycles
  • If you take a daily migraine prevention medicine, the dose has been the same for 3 months and will stay the same during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06659120Recruiting
Fremanezumab to prevent period-related migraines

This study tests whether the migraine prevention drug fremanezumab can reduce the number of migraines you get around your period. It is for women who have regular cycles and migraines that are clearly linked to their menstrual period.

Bern
NCT04743141Recruiting· Phase 3
Long-term migraine medicine study for kids with migraine attacks

This Phase 3 study checks the long-term safety of rimegepant, a migraine treatment, in children and teens. You might join if your child has had migraine for at least 6 months and still gets a certain number of moderate-to-severe migraine attacks.

Scottsdale, Arizona
NCT06401642Recruiting· Phase 4
Zavegepant for acute migraine with CGRP preventives

This study tests how well a new acute migraine medicine, zavegepant, works and is tolerated in people who are already taking a CGRP-targeting preventive medication. It may help you find an effective treatment when you get a migraine attack.

Phoenix, Arizona
NCT06409832Recruiting
Study of rimegepant for migraine prevention

This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.

Florence, Florence
NCT06728345Not yet recruiting
Rimegepant for preventing migraine in women in China

This study tests if the drug rimegepant can help prevent migraine attacks in women. It aims to see how well it works in real life in China.

NCT07729462Not yet recruiting· Phase 3
Rimegepant for preventing chronic migraine

This study tests whether the medication rimegepant can help prevent chronic migraine in adults. It may be an option if you have frequent migraines and have not tried certain other preventive treatments.

Canoga Park, California

Hear when a new Menstrual Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.